MedPath

Pharmaceutical Companies

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
2002-01-01
Employees
197
Market Cap
$1.2B
Website
http://www.collegiumpharma.com

INNOVIVA

πŸ‡«πŸ‡·France
Ownership
-
Established
-
Employees
-
Market Cap
$1.1B
Website
-
Gyre Therapeutics logo

Gyre Therapeutics

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public, Subsidiary
Established
1997-01-01
Employees
4
Market Cap
$1.1B
Website
http://www.catalystbiosciences.com

Prothena

πŸ‡§πŸ‡ͺBelgium
Ownership
-
Established
-
Employees
173
Market Cap
$1.1B
Website
-
TYRA BIOSCIENCES, INC. logo

TYRA BIOSCIENCES, INC.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
2018-01-01
Employees
49
Market Cap
$1.1B
Website
http://www.tyra.bio
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SN?P, enables the...

Immatics

πŸ‡©πŸ‡ͺGermany
Ownership
-
Established
-
Employees
343
Market Cap
$1.1B
Website
-
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics....
AnaptysBio logo

AnaptysBio

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
2005-01-01
Employees
117
Market Cap
$1.1B
Website
http://www.anaptysbio.com
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural...
Ownership
-
Established
-
Employees
-
Market Cap
$1.1B
Website
-

Calliditas Therapeutics, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$1B
Website
-

Cullinan Therapeutics

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
85
Market Cap
$1B
Website
-
Cullinan Management, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.
Β© Copyright 2025. All Rights Reserved by MedPath